Intra-arterial Hepatic Chemotherapy, Chemoembolisation and Radioembolisation: a Significant Contribution in the Treatment of Colorectal Cancer Liver Metastases

被引：0
|
作者：
Pernot, S. [1 ]
Pellerin, O. [2 ]
Ghazzar, N. [3 ]
Vaillant, J. N. [1 ]
Lepere, C. [1 ]
Sapoval, M. [2 ]
Taieb, J. [1 ]
Rougier, P. [1 ]
机构：
[1] Univ Paris 05, CHU Georges Pompidou HEGP, Assistance Publ Hop Paris, Serv HGE & Oncol Digest, F-75015 Paris, France
[2] Univ Paris 05, CHU Georges Pompidou HEGP, Assistance Publ Hop Paris, Serv Radiol Intervent, F-75015 Paris, France
[3] Univ Paris 05, CHU Georges Pompidou HEGP, Assistance Publ Hop Paris, Dept Med Nucl, F-75015 Paris, France
来源：
ONCOLOGIE | 2014年 / 16卷 / 11-12期
关键词：
Hepatic arterial infusion; Hepatic intra-arterial chemotherapy; Chemoembolisation; Radioembolisation; Colorectal cancers; Liver metastases; Y-90 RESIN MICROSPHERES; ARTERIAL INFUSION; SYSTEMIC CHEMOTHERAPY; COMPLETE RESPONSE; RANDOMIZED-TRIAL; PHASE-II; OXALIPLATIN; IRINOTECAN; RESECTION; RADIOEMBOLIZATION;
D O I：
10.1007/s10269-014-2468-x
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Local treatment of liver metastases (LM) of colorectal adenocarcinomas (CRC) has an emerging role in strategies of treatment for patients with limited or predominant unresectable LM. Hepatic intra-arterial chemotherapy (HIAC) demonstrated efficacy. Its combination with systemic chemotherapy allowed to double the response rate, and increased the rate of secondary resection and survival of patients. The effectiveness of chemoembolization (CE) and radio-embolization (RE) was primarily established from Phase II or Phase III evaluation of patients in very advanced stages, and progression-free survival and overall survival were increased. The role of these treatments at earlier stages is being evaluated and is expected to optimize the care of patients with LM. These local treatments must now be used in combination with effective systemic therapies, and/or resection, and the choice of the best strategies and protocols must be done in specialized team with collaboration of expert radiologist, nuclear medicine and oncologist.
引用
收藏
页码：S571 / S578
页数：8
相关论文
共 50 条
  • [21] Downstaging of hepatocellular carcinoma and liver metastases from colorectal cancer by selective intra-arterial chemotherapy
    Clavien, PA
    Selzner, N
    Morse, M
    Selzner, M
    Paulson, E
    SURGERY, 2002, 131 (04) : 433 - 442
  • [22] INTRA-ARTERIAL CHEMOTHERAPY IN TREATMENT OF PRIMARY LIVER CANCER
    LANGE, M
    FALKSON, G
    GEDDES, E
    SOUTH AFRICAN JOURNAL OF SURGERY, 1974, 12 (02) : 66 - 66
  • [23] Phase 2 of intra-arterial hepatic (IAH) bevacizumab with systemic chemotherapy (CT) in second line treatment of liver metastases of colorectal cancer (LMCRC)
    Ducreux, Michel
    Glehen, Olivier
    Tergemina-Clain, Gabrielle
    Smith, Denis Michel
    Lacas, Benjamin
    Boige, Valerie
    Passot, Guillaume
    Malka, David
    Pignon, Jean-Pierre
    Dupont-Bierre, Eric
    Guimbaud, Rosine
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [24] Phase 2 of intra-arterial hepatic (IAH) bevacizumab with systemic chemotherapy (CT) in second line treatment of liver metastases of colorectal cancer (LMCRC)
    Ducreux, M. P.
    Glehen, O.
    Tergemina-Clain, G.
    Smith, D.
    Lacas, B.
    Boige, V.
    Malka, D.
    Pignon, J-P.
    Dupont-Bierre, E.
    Guimbaud, R.
    ANNALS OF ONCOLOGY, 2016, 27
  • [25] Cetuximab with hepatic arterial infusion of chemotherapy for the treatment of colorectal cancer liver metastases
    Neyns, Bart
    Aerts, Maridi
    Van Nieuwenhove, Yves
    Fontaine, Christel
    De Coster, Lore
    Schallier, Dennis
    Vanderauwera, Jacques
    De Munck, Floris
    Vandenbroucke, Frederik
    Everaert, Hendrik
    Meert, Vanessa
    De Mey, Johan
    De Ridder, Mark
    Delvaux, Georges
    De Greve, Jacques
    ANTICANCER RESEARCH, 2008, 28 (4C) : 2459 - 2467
  • [26] CETUXIMAB WITH HEPATIC ARTERIAL INFUSION OF CHEMOTHERAPY FOR THE TREATMENT OF COLORECTAL CANCER LIVER METASTASES
    Neyns, B.
    Aerts, M.
    Van Nieuwenhove, Y.
    Fontaine, C.
    De Coster, L.
    Schallier, D.
    Vanderauwera, J.
    De Munck, F.
    Vandenbroucke, F.
    Everaert, H.
    Meert, V.
    De Mey, J.
    De Ridder, M.
    Delvaux, G.
    De Greve, J.
    ANTICANCER RESEARCH, 2008, 28 (5C) : 3185 - 3186
  • [27] Intra-arterial therapies for colorectal cancer liver metastases (radioembolization excluded)
    de Baere, Thierry
    Tselikas, Lambros
    Boige, Valerie
    Ducreux, Michel
    Malka, David
    Goere, Diane
    Benahim, Eleonore
    Deschamps, Frederic
    BULLETIN DU CANCER, 2017, 104 (05) : 402 - 406
  • [28] Intra-arterial hepatic chemotherapy for unresectable colorectal liver metastases: a review of medical devices complications in 3172 patients
    Bacchetti, Stefano
    Pasqual, Enricomaria
    Crozzolo, Elena
    Pellarin, Alessandra
    Cagol, Pier Paolo
    MEDICAL DEVICES-EVIDENCE AND RESEARCH, 2009, 2 : 31 - 40
  • [29] Hepatic intra-arterial chemotherapy in the treatment of unresectable colorectal hepatic metastasis - Case reports
    Mancini, R
    Garufi, C
    Pugliese, P
    Perrone, M
    Caterino, M
    Giunta, S
    Cosimelli, M
    TUMORI, 2002, : S30 - S32
  • [30] A case controlled study on the effect of intra-arterial chemotherapy in patients with colorectal cancer liver metastases.
    Kitazumi, Y
    Suzuki, K
    Obara, T
    Iimuro, M
    Takahashi, M
    Kuwayama, H
    GASTROENTEROLOGY, 2002, 122 (04) : A597 - A597
12345